Trials / Conditions / Locally Advanced Lung Non-Small Cell Carcinoma

Locally Advanced Lung Non-Small Cell Carcinoma

15 registered clinical trials studyying Locally Advanced Lung Non-Small Cell Carcinoma — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non- NCT07012031	National Cancer Institute (NCI)	Phase 1 / Phase 2
Recruiting	Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location NCT06361784	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	—
Recruiting	Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable N NCT05624996	NRG Oncology	Phase 3
Recruiting	Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli NCT05269381	Mayo Clinic	Phase 1 / Phase 2
Active Not Recruiting	Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer NCT05166616	City of Hope Medical Center	Phase 1
Terminated	ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy NCT04372927	University of Washington	Phase 2
Recruiting	Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer NCT05136846	Ohio State University Comprehensive Cancer Center	Phase 1
Active Not Recruiting	Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or NCT04940299	M.D. Anderson Cancer Center	Phase 2
Recruiting	Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Mo NCT05010109	M.D. Anderson Cancer Center	N/A
Recruiting	Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-s NCT04751747	Rutgers, The State University of New Jersey	N/A
Active Not Recruiting	Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCL NCT04227028	City of Hope Medical Center	Phase 1
Completed	Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plu NCT03801902	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small L NCT04013542	M.D. Anderson Cancer Center	Phase 1
Completed	Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medication NCT02595866	National Cancer Institute (NCI)	Phase 1
Completed	Stereotactic Ablative Radiotherapy in Locally Advanced Non Small Cell Lung Cancer NCT05291780	Radiotherapy Oncology Centre "Santa Maria" Hospital	N/A